Middle East Media Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Media Times.

Press releases published on May 12, 2026

8 minutes ago

Newsmatics Launches 'Journalists Wanted' Initiative to Amplify Credible Journalism and Expand Audience Reach

Indeterminate EIN Presswire

5 hours ago

GyanBatua.AI Launches AI Career-Readiness Platform for Job Seekers

Indeterminate EIN Presswire

5 hours ago

National Security Expert Joe Kaufman Launches Campaign for Florida’s New 25th Congressional District

Indeterminate EIN Presswire

8 hours ago

Hormuz Disruption Drives New Infrastructure Vision: ZNERA’s Strait of Union Visualized by Omegarender

Indeterminate EIN Presswire

1 hours ago

First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026 

Indeterminate GlobeNewswire

2 hours ago

Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel’s Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026

Indeterminate GlobeNewswire

2 hours ago

Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress

Indeterminate GlobeNewswire

2 hours ago

Picogrid Joins U.S. Army’s “Right to Integrate” Sprint at Fort Carson to Accelerate Vendor-Neutral Interoperability

Indeterminate GlobeNewswire

2 hours ago

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress

Indeterminate GlobeNewswire

2 hours ago

Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting

Indeterminate GlobeNewswire

2 hours ago

BlossomHill Therapeutics to Present Initial Clinical Dose Escalation Data from the Phase 1/1b Trial of BH-30236 in Patients with R/R AML or HR-MDS at EHA2026

Indeterminate GlobeNewswire

2 hours ago

Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias

Indeterminate GlobeNewswire

2 hours ago

Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress

Indeterminate GlobeNewswire

2 hours ago

Alpha Compute Closes $32.2 Million Revenue Contract with AI Lab Customer

Indeterminate GlobeNewswire

2 hours ago

Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress

Indeterminate GlobeNewswire

2 hours ago

Cellectis présentera des données cliniques sur lasmé-cel et éti-cel au congrès annuel de l’EHA 2026

Indeterminate GlobeNewswire

2 hours ago

Independent Cleveland Clinic Review Finds No Clinically Significant Cardiotoxicity with Moleculin's Annamycin in R/R AML Patients Dosed Beyond Conventional Anthracycline Limits

Indeterminate GlobeNewswire

2 hours ago

South Street Securities Holdings Inc. Acquires 100% Equity Interest in Lime Funding LLC, an Asset-Backed Commercial Paper Conduit

Indeterminate GlobeNewswire

2 hours ago

Zodiac Partners II, LLC Launches a $46 million Tender Offer to Acquire Destination XL Group, Inc. for $0.82 Per Share in Cash

Indeterminate GlobeNewswire

2 hours ago

OOH Delivers 2x the Performance Lift of TV, New OAAA and Kochava Study Finds

Indeterminate GlobeNewswire